Stock Analysis

Micro-X (ASX:MX1) is continuing to develop its position in the medical technology sector through its lightweight X-ray imaging platforms and emerging healthcare applications. The Adelaide-based company is focused on commercialising its carbon nanotube-enabled technology across mobile medical imaging, stroke diagnostics and security screening markets.

AML3D (ASX:AL3) is advancing its position in the global metal additive manufacturing sector through its Wire Additive Manufacturing (WAM) technology and ARCEMY industrial 3D printing systems. The company is focused on supplying advanced manufacturing solutions for defence, aerospace, maritime and industrial applications, with the …

EML Payments (ASX:EML) delivered its FY26 results following a multi-year restructuring period aimed at rebuilding theBusinessafter regulatory challenges and operational changes.

Enero Group (ASX:EGG) delivered its FY26 results on 21 August 2026, highlighting a significant improvement in profitability despite a decline in revenue across the business.

Tuas (ASX:TUA) has entered a new phase after the collapse of its planned acquisition of Singapore telecommunications operator M1, shifting the focus back to the organic growth strategy of its Simba Telecom business.

Argenica Therapeutics (ASX:AGN) continues progressing development of its lead neuroprotective peptide Xaranetide, with recent safety milestones and additional research supporting the company’s next clinical steps.

Myer Holdings (ASX:MYR) provided its FY26 trading update on 27 July 2026, highlighting continued progress across its transformation strategy while acknowledging a more difficult retail environment in the second half of the financial year.